# HwaGen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hwagen

- Industry: Pharmaceuticals
- Headquarters: Shenzhen, China
- Website: www.hwagenpharm.com
- Total disclosed funding: $52M
- Latest round: Series B (Dec 16, 2022)
- Investors on record: 12

## About

Founded in 2015 and based in Shenzhen, China, HwaGen is a pharmaceutical technology company that focuses on R&D of pharmaceutical APIs and intermediates. The company has 1800 square meters of R&D and office space. As of 2022, it has more than 50 employees.

The company's main products include pazopani hydrochloride, veranterol triphenylacetate, dulutvir sodium salt and pharmaceutical intermediates. Its products are used in anti-tumor, anti-virus, anti-respiratory diseases and other fields.

## Funding rounds

- Series B, Dec 16, 2022, $14M — Guangdong Technology Financial Group, Tuowei (Zhuhai) Venture Capital, Investment and development of Hangzhou Jiande High speed Railway New Area
- Series B, Sep 1, 2021, $23M — Renhe Capital, China Reform Holdings, Suzhou Xiangcheng Fund, Shenzhen Jiayin Fund Management
- Series A, May 6, 2020, $14M — Toposcend Capital, Winzac Capital Management, Realharmony Capital, Wuming Venture, Shenzhen Lvyao Weizhong Technology
- Angel, Sep 5, 2016 — Wuming Venture

## Investors

- Wuming Venture (https://capitalatlas.ai/funds/wuming-venture) — Angel, Series A
- Toposcend Capital (https://capitalatlas.ai/funds/toposcend-capital) — Series A
- Winzac Capital Management (https://capitalatlas.ai/funds/winzac-capital-management) — Series A
- Realharmony Capital (https://capitalatlas.ai/funds/realharmony-capital) — Series A
- Shenzhen Lvyao Weizhong Technology — Series A
- Renhe Capital (https://capitalatlas.ai/funds/renhe-capital) — Series B
- China Reform Holdings (https://capitalatlas.ai/funds/china-reform-holdings) — Series B
- Suzhou Xiangcheng Fund (https://capitalatlas.ai/funds/suzhou-xiangcheng-fund) — Series B
- Shenzhen Jiayin Fund Management — Series B
- Guangdong Technology Financial Group (https://capitalatlas.ai/funds/guangdong-technology-financial-group) — Series B
- Tuowei (Zhuhai) Venture Capital — Series B
- Investment and development of Hangzhou Jiande High speed Railway New Area — Series B